EVARF (EVARF) Stock Price & Analysis
EVARF (EVARF) rose 0.00% to USD 0 as of June 10, 2026 at 20:45 UTC, according to Nexqual real-time market data.
EVARF last closed at USD 0; the session ranged USD 0–0 on volume of 125 shares. Market capitalization is $2,795, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 20:45 UTC.
Key Statistics (as of June 10, 2026 at 20:45 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 125 shares |
| Market Cap | $2,795 |
| Exchange | PNK |
Technical Analysis (EVARF)
Nexqual's technical model rates EVARF "STRONG SELL" based on 0 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 20:45 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (EVARF)
Wall Street analysts rate EVARF "None", per Nexqual as of June 10, 2026 at 20:45 UTC.
| Consensus Rating | None |
|---|
Earnings (EVARF)
Source: Nexqual, June 10, 2026 at 20:45 UTC.
Financials & Fundamentals (EVARF)
| Total Revenue | $12.17M |
|---|---|
| Revenue Growth (YoY) | -18.50% |
| Gross Margin | +9.38% |
| Operating Margin | -172.63% |
| Profit Margin | -255.03% |
| ROE | -108.73% |
| Debt / Equity | 247.33 |
| Current Ratio | 3.33 |
| Total Cash | $20.80M |
| Total Debt | $34.56M |
| Free Cash Flow | $-17.21M |
Source: Nexqual, June 10, 2026 at 20:45 UTC.
Financial Health Score (EVARF)
Nexqual rates EVARF's overall financial health "Critical" across five dimensions, as of June 10, 2026 at 20:45 UTC.
| Growth | Critical — Revenue -19% YoY (annual), sharp decline |
|---|---|
| Profitability | Critical — Heavily loss-making — early-stage company |
| Balance Sheet | Weak — $21M cash vs $35M debt |
| Cash Flow | Weak — FCF negative: -$17M, burning cash |
| Efficiency | Critical — ROE -109%, ROA -20.8% |
Ownership (EVARF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 27.95M |
| Float | 19.59M |
| Short % of Float | +0.35% |
Source: Nexqual, June 10, 2026 at 20:45 UTC.
Leadership (EVARF)
EVARF is led by Kurt B. Lemvigh (age 65), Chief Executive Officer, per Nexqual as of June 10, 2026 at 20:45 UTC.
| Chief Executive Officer | Kurt B. Lemvigh (age 65) |
|---|---|
| Chief Technology Officer | Peter Phillips (age 66) |
| Vice President of Operations | Andrew Debbage |
| Vice President of Sales & Marketing | Jonathan Hornsby |
| Vice President of Human Resources | Kate Forster |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| RGDXQ | RESPONSE GENETICS INC | USD 0 | ▲ 0% |
| LINUF | LINIU TECHNOLOGY GROUP | USD 0 | ▲ 0% |
| MDIT | MEDITE CANCER DIAGNOSTICS INC | USD 0 | ▲ 0% |
| ERINQ | ERIN ENERGY CORP | USD 0 | ▲ 0% |
| TNGNQ | TENGION INC | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 20:45 UTC. This page is informational and not investment advice.